Hôpital Européen Georges Pompidou
Paris, 75015, France
NCT Number: NCT00604149
Sudden death is a major problem in industrially developed countries. Despite a decline in ischemic heart disease mortality and the progress has been made in resuscitation, treatment of sudden death victims is frequently unsuccessful. the ideal solution would be to prevent the disease process that causes the initial episode of cardiac arrest. Parental sudden death is an independent risk factor for sudden death. So, detect a gene predisposing to sudden death may help provide better identification of subjects at high risk of cardiac arrest. This research is a genetic study of sudden cardiac death, recruited 2000 subjects in out-of-hospital cardiac arrest.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Observational
Paris, 75015, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Day 1
DNA extracted from blood cells
Institut National de la Santé Et de la Recherche Médicale, France
Other Gov
Etude Multicentrique en Population de la susceptibilité génétique à Faire Une Mort Subite
Acronym: CARTAGENE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03835403
Cardiovascular Diseases, Heart Arrest
Copenhagen, Ballerup, Denmark
View Trial DetailsNCT02309151
Cardiovascular Diseases, Heart Arrest
Aalborg, Denmark
View Trial DetailsNCT04237727
Cardiovascular Diseases, Heart Arrest
Amersfoort, Utrecht, Netherlands
View Trial DetailsNCT05062785
Cardiovascular Diseases, Healthy
Ann Arbor, Michigan, United States
View Trial Details